Efavirenz Tablet, Film Coated
Product Images NDC 69097-301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Efavirenz (NDC 69097-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fd28d7f3 45a8 429d B719 173b3e31812b 01

FDA Label Image

Fd28d7f3 45a8 429d B719 173b3e31812b 02

Fd28d7f3 45a8 429d B719 173b3e31812b 02
Each film-coated tablet contains 600 mg dose; For dosage and full prescribing information, read AVIFENZ. Store at 25°C (77°F). Tablets are manufactured by Cipla Ltd., Verna Goa, India, for Cipla USA Inc. Keep out of reach of children. The text may correspond to a medication package insert or label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.